Found 9 matching trials
Efficacy and Safety of Lisdexamfetamine Dimesylate in Adults With Chronic Fatigue Syndrome PHASE4 Over the past decade, the Rochester Center for Behavioral Medicine (RCBM) h...
Show More Location
Rochester Center for Behavioral Medicine
Learn More & Join Trial
A Comparison of PRC-063 and Lisdexamfetamine in the Driving Performance of Adults With ADHD PHASE3 The purpose of this randomized, double-blind, crossover study is to compare...
Show More Location
University of Virginia
Learn More & Join Trial
Effect of Vyvanse on Sleep in Children Aged 6-12 Years With Attention Deficit Hyperactivity Disorder (ADHD) NA This study involves research to test how Vyvanse (study drug) affects sleep...
Show More Location
Clinical Study Centers, LLC
Learn More & Join Trial
Safety and Efficacy of SPD489 on Executive Function Behaviors in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD) PHASE4 The primary objective of the study is to evaluate the efficacy of SPD489 co...
Show More Location
Clinical Study Centers, LLC
Learn More & Join Trial
Effect of Vyvanse on Driving in Young Adults With ADHD PHASE4 The primary objective of the study is to assess the benefice of Vyvanse on ...
Show More Location
Massachusetts General Hospital
Learn More & Join Trial
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder PHASE3 This study will examine SPD489 in subjects aged 18-65 with major depressive...
Show More Location
Birmingham Research Group
Learn More & Join Trial
Safety and Efficacy Workplace Environment Study of Lisdexamfetamine Dimesylate (LDX) in Adults With Attention-Deficit Hyperactivity Disorder (ADHD) PHASE3 To evaluate the efficacy of LDX compared to placebo in adults with ADHD in ...
Show More Location
Clinical Study Centers, LLC
Learn More & Join Trial
A Classroom Study to Assess the Time of Onset of Vyvanse (Lisdexamfetamine Dimesylate) in Pediatric Subjects Aged 6-12 With Attention Deficit/Hyperactivity Disorder (ADHD) PHASE3 The primary objective of this study is to assess the time of onset of Vyvan...
Show More Location
Clinical Study Centers, LLC
Learn More & Join Trial
Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder PHASE3 This study will examine SPD489 in subjects aged 18-65 with major depressive...
Show More Location
ResearchOne, Inc.
Learn More & Join Trial